LMAT

LeMaitre Vascular, Inc.'s stock price declined by 29.6% as of August 5, 2026, and 27% as of October 1, 2026, from its all-time high of $118.01 USD on April 13, 2026. Key events include Q1 2026 earnings on May 5, 2026, which reported increased sales, gross margin, operating income, and diluted EPS, along with a declared dividend and share repurchase program. Q2 2026 earnings on August 4, 2026, showed increased net sales and diluted EPS but missed analyst expectations for both revenue and EPS. This miss, coupled with reduced full-year guidance and FDA findings at its Artegraft plant, contributed to the stock's decline. The company's CFO participated in investor conferences in September 2026, and a dividend of $0.25 per share was paid on September 3, 2026. Technical indicators showed the Momentum Indicator turning positive on September 22, 2026, the Aroon Indicator entering a downward trend on September 25, 2026, and the Stochastic Oscillator being in the overbought zone for one day as of October 1, 2026.